| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Tumor Biology |
Radiation Oncology Branch, National Cancer Institute, NIH, Bethesda, Maryland [K. C., C. M., M. S.]; Departments of Surgery [M. A. M., J. F.] and Cell Biology [J. F.], Harvard Medical School, Boston, Massachusetts; Laboratory for Surgical Research and the Department of Surgery, Childrens Hospital, Boston, Massachusetts [M. A. M., J. F.]; Department of Radiation Oncology and Cancer Biology, M. D. Anderson Cancer Center, Houston, Texas [M. S. O.]; and Department of Urology, J. W. Goethe University, Frankfurt, Germany [W-D. B.]
The observation that radiation treatment to a local area of the body results in an antitumor effect for tumors distant to the radiation site has been termed the "abscopal effect." To understand the mechanism of this unusual phenomenon, we examined whether the effect was mediated through p53, a protein complex up-regulated in irradiated cells. Non-tumor-bearing legs of C57BL/6 (wild-type p53) and p53 null B6.129S2-Trp53tm1Tyj mice were irradiated to determine whether an abscopal effect could be observed against Lewis lung carcinoma (LLC) and T241 (fibrosarcoma) implanted at a distant site. In mice with wild-type p53, both LLC and T241 tumors implanted into the midline dorsum grew at a significantly slower rate when the leg of the animal was exposed to five 10-Gy fractions of radiation compared with sham-irradiated animals, suggesting that the abscopal effect is not tumor specific. When the radiation dose to the leg was reduced (twelve fractions of 2 Gy each), the inhibition of LLC tumor growth was decreased indicating a radiation-dose dependency for the abscopal effect. In contrast, when the legs of p53 null animals or wild-type p53 mice treated with pifithrin-
(a p53 blocker) were irradiated (five 10-Gy fractions), tumor growth was not delayed. These data implicate p53 as a key mediator of the radiation-induced abscopal effect and suggest that pathways downstream of p53 are important in eliciting this response.
This article has been cited by other articles:
![]() |
K. Shiraishi, Y. Ishiwata, K. Nakagawa, S. Yokochi, C. Taruki, T. Akuta, K. Ohtomo, K. Matsushima, T. Tamatani, and S. Kanegasaki Enhancement of Antitumor Radiation Efficacy and Consistent Induction of the Abscopal Effect in Mice by ECI301, an Active Variant of Macrophage Inflammatory Protein-1{alpha} Clin. Cancer Res., February 15, 2008; 14(4): 1159 - 1166. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Sgouros, S. J. Knox, M. C. Joiner, W. F. Morgan, and A. I. Kassis MIRD Continuing Education: Bystander and Low Dose-Rate Effects: Are These Relevant to Radionuclide Therapy? J. Nucl. Med., October 1, 2007; 48(10): 1683 - 1691. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Koturbash, A. Boyko, R. Rodriguez-Juarez, R. J. McDonald, V. P. Tryndyak, I. Kovalchuk, I. P. Pogribny, and O. Kovalchuk Role of epigenetic effectors in maintenance of the long-term persistent bystander effect in spleen in vivo Carcinogenesis, August 1, 2007; 28(8): 1831 - 1838. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Prise New advances in radiation biology Occup. Med., May 1, 2006; 56(3): 156 - 161. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. F. Morgan and M. B. Sowa Effects of ionizing radiation in nonirradiated cells PNAS, October 4, 2005; 102(40): 14127 - 14128. [Full Text] [PDF] |
||||
![]() |
C Mothersill, M J Moriarty, and C B Seymour Bystander and other delayed effects and multi-organ involvement and failure following high dose exposure to ionising radiation Br. J. Radiol., January 1, 2005; Supplement_27(1): 128 - 131. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Huang, S. Grim, L. E. Smith, P. M. Kim, J. A. Nickoloff, O. G. Goloubeva, and W. F. Morgan Ionizing Radiation Induces Delayed Hyperrecombination in Mammalian Cells Mol. Cell. Biol., June 1, 2004; 24(11): 5060 - 5068. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. I Azzam and J. B Little The radiation-induced bystander effect: evidence and significance Human and Experimental Toxicology, February 1, 2004; 23(2): 61 - 65. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |